SPOTLIGHT: Abbott edges Genentech in CEO tourney

Remember the Pharma CEO tournament bracket the Wall Street Journal Health Blog came up with a few weeks ago? Well, the competition was fierce, but the predictions are in. The chosen winner? Miles White (photo), CEO of Abbott Labs, who won by a nose over Genentech CEO Art Levinson (photo). White got 40 percent of 12,000 votes compared with Levinson's 39 percent. Report

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.